This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

NewAge Dirección

Dirección controles de criterios 2/4

Información clave

Darren Zobrist

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	2.3yrs
Promedio de permanencia en la Junta Directiva	3.2yrs

Actualizaciones recientes de la dirección

Recent updates

NewAge files for chapter 11 bankruptcy

Aug 30

NewAge receives Nasdaq notice for non-compliance

Aug 18

New Age: 4 Catalysts That We Like Including A Valuation That Is Too Cheap To Ignore

Jul 05

Party Time: Brokers Just Made Major Increases To Their NewAge, Inc. (NASDAQ:NBEV) Earnings Forecasts

Dec 11

NewAge secures new $30M debt facility, shares slide ~4% premarket

Dec 01

NewAge brings in ARIIX to bolster DTC business

Nov 16

NewAge Was Hot Before Recent Cannabis Resurgence - Will Remain Hot

Nov 13

NewAge EPS misses by $0.08, misses on revenue

Nov 09

CEO

Darren Zobrist

no data

Permanencia

Darren Zobrist is Chief Executive Officer of NewAge, Inc.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Darren Zobrist	Chief Executive Officer	no data	sin datos	sin datos
Mark Wilson	Group President	2.3yrs	sin datos	sin datos
Kevin Manion	Chief Financial Officer	no data	sin datos	0.13% $ 21.4
Phil Lewis	Senior Vice President of Operations	no data	sin datos	sin datos
Lisa Mueller	Vice President of Investor Relations	no data	sin datos	sin datos
Jennifer Grafton	Senior VP & General Counsel	1.3yrs	sin datos	sin datos
Michael Cunningham	Senior Vice President of Sales	no data	sin datos	sin datos
Deanna Latson	Chief Product & Marketing Officer	no data	sin datos	sin datos
Liz Martinez	Chief Human Resources Officer	no data	sin datos	sin datos
Jay Barrow	Head of Brand	no data	sin datos	sin datos
Kelly Olsen	Chief Commercial Officer	4.3yrs	sin datos	sin datos
Randy Looper	President of New Age Health Sciences Divisions	no data	sin datos	sin datos

2.3yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: NBEV.Q's management team is considered experienced (2.3 years average tenure).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Edward Brennan	Chairman	6.2yrs	US$170.00k	1.17% $ 197.2
Frederick Cooper	Director	2.3yrs	US$39.30k	7.18% $ 1.2k
Michele Crocker	Director	less than a year	sin datos	sin datos
Gregory Fea	Independent Non-Executive Director	6.2yrs	US$287.50k	sin datos
Amy Kuzdowicz	Independent Director	4.1yrs	US$177.50k	sin datos
Judith Hammerschmidt	Director	1.3yrs	sin datos	sin datos

3.2yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: NBEV.Q's board of directors are considered experienced (3.2 years average tenure).

This company is no longer active

NewAge Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

NewAge, Inc. Announces Executive Changes

Less than half of directors are independent

NewAge, Inc. Appoints Michele Crocker to its Board of Directors

Independent Director recently bought US$608k worth of stock

NewAge, Inc. Announces Board Changes

Recent updates

Rosen Law Firm Files Securities Class Action Lawsuit Against NewAge, Inc

Nasdaq to Delist Common Stock of NewAge

Newage Announces That Its Common Stock Has Ceased Trading on Nasdaq

Motion for Joint Administration Filed by NewAge, Inc.

DIP Financing, LLC entered into an asset purchase agreement to acquire all of the assets from NewAge, Inc. (NasdaqCM:NBEV), Morinda, Inc, Morinda Holdings, Inc. and Ariix LLC for $28 million.

NewAge files for chapter 11 bankruptcy

NewAge Receives Additional Delinquency Notice from Nasdaq on Late Filing of its Form 10-Q

NewAge receives Nasdaq notice for non-compliance

NewAge, Inc. Receives Notice of Default Letter from East West Bank

Less than half of directors are independent

NewAge, Inc. Announces Executive Changes

New Age: 4 Catalysts That We Like Including A Valuation That Is Too Cheap To Ignore

Cologne List® Adds NewAge, Inc.'s Nutrifii™ Renew to Certification List

Newage, Inc. Receives Nasdaq Notice on Late Filing of Its Form 10-Q

NewAge, Inc. announced delayed 10-Q filing

NewAge, Inc. Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K

Less than half of directors are independent

NewAge, Inc. Appoints Michele Crocker to its Board of Directors

NewAge, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Consensus forecasts updated

Price target decreased to US$3.33

NewAge, Inc. Provides Revenue Guidance for the Fourth Quarter Ended December 31, 2021

Is NewAge (NASDAQ:NBEV) Using Debt Sensibly?

Independent Director recently bought US$608k worth of stock

Third quarter 2021 earnings released: US$0.018 loss per share (vs US$0.14 loss in 3Q 2020)

NewAge, Inc. Publishes Major New Discovery on Blocking Spike Proteins from Binding to Human Cells

Health Check: How Prudently Does NewAge (NASDAQ:NBEV) Use Debt?

Price target decreased to US$5.50

Second quarter 2021 earnings released: EPS US$0.12 (vs US$0.10 loss in 2Q 2020)

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Chief Financial Officer Gregory Gould has left the company

Forecast breakeven pushed back to 2022

Price target decreased to US$5.00

NewAge, Inc. (NasdaqCM:NBEV) completed the acquisition of Aliven Inc.

NewAge, Inc. Launches New Children’s Multivitamin With Better Absorption for Immune System Support

NewAge updates on strong growth for Europe business

NewAge Launches New Ocean Friendly, Safe and Effective Sunscreen to the Lucim™ Skincare Line

NewAge, Inc. announced delayed annual 10-K filing

NewAge, Inc. (NasdaqCM:NBEV) entered into an agreement to acquire Aliven Inc. for $2.8 million.

Koios Beverage Corp. Enters into A Distribution Agreement with Newage, Inc

The NewAge (NASDAQ:NBEV) Share Price Is Up 880% And Shareholders Are Delighted

NewAge, Inc. announced that it expects to receive $57.960469 million in funding

NewAge, Inc. to Report Q4, 2020 Results on Mar 16, 2021

New 90-day high: US$3.56

Party Time: Brokers Just Made Major Increases To Their NewAge, Inc. (NASDAQ:NBEV) Earnings Forecasts

NewAge secures new $30M debt facility, shares slide ~4% premarket

NewAge, Inc. Announces Board Changes

New Age Beverages Corporation (NasdaqCM:NBEV) completed the acquisition of ARIIX Holdings, LLC from certain members of Ariix Holdings, LLC.

NewAge brings in ARIIX to bolster DTC business

NewAge Was Hot Before Recent Cannabis Resurgence - Will Remain Hot

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: US$0.14 loss per share

NewAge EPS misses by $0.08, misses on revenue

New 90-day high: US$3.00

NewAge, Inc. to Report Q3, 2020 Results on Nov 09, 2020

New 90-day high: US$2.43

New Age Beverages Corporation (NasdaqCM:NBEV) entered into an agreement to acquire ARIIX Holdings, LLC from certain members of Ariix Holdings, LLC for approximately $280 million.

Zachert Private Equity GmbH acquired all of the membership interests in Brands Within Reach, LLC (BWR) from NewAge, Inc. (NasdaqCM:NBEV) in a deal valued at $15 million.

First half earnings released

NewAge, Inc. to Report Q2, 2020 Results on Aug 10, 2020

New 90-day high - US$2.46

Price target raised to US$6.00

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta